Is CVRx, Inc. (CVRX) a Buy, Sell, or Hold?
NASDAQ : CVRX
CVRx, Inc. — Institutional Ownership
$5.5 USD
$0.33 (6.28%)
- Volume
- 128.81K
- Average Volume
- 311.26K
- Market Capitalization
- $145.95M
- P/E Ratio
- -2.72
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $11.30
- Year Low
- $4.37
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.20
Institutional Ownership Summary
Institutional Ownership %
0.59%
Investors Holding
17
change: -84 | last: 101
Increased Positions
5
change: -52 | last: 57
Reduced Positions
5
change: -16 | last: 21
New Positions
0
change: -24 | last: 24
Sold Positions
82
change: 67 | last: 15
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -53.0201 | last: 0.5302
Total Invested
807.86K
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-01-12 | JOHNSON & JOHNSON | 4.02M | 15.40% |
| 2025-02-20 | New Enterprise Associates VIII, Limited Partnership | - | 0.00% |
| 2025-02-20 | NEA Partners 10, Limited Partnership | 2.03M | 7.80% |
| 2025-02-20 | New Enterprise Associates 8A, Limited Partnership | - | 0.00% |
| 2025-02-20 | New Enterprise Associates 10, Limited Partnership | 2.03M | 7.80% |
| 2025-02-20 | Mohamad H. Makhzoumi | 2.03M | 7.80% |
| 2025-02-20 | Anthony A. Florence, Jr. | 2.03M | 7.80% |
| 2025-02-20 | Scott D. Sandell | 2.03M | 7.80% |
| 2025-02-20 | NEA Partners VIII, Limited Partnership | - | 0.00% |
| 2025-02-06 | Gilde Healthcare IV Management B.V. | 1.23M | 4.90% |
| 2025-02-06 | Gilde Healthcare Holding B.V. | 1.23M | 4.90% |
| 2025-02-06 | Manapouri B.V. | 1.23M | 4.90% |
| 2025-02-06 | Martemanshurk B.V. | 1.23M | 4.90% |
| 2025-02-06 | Vensana Capital I GP, LLC | 1.71M | 7.10% |
| 2025-02-06 | Cooperatieve Gilde Healthcare IV U.A. | 1.23M | 4.90% |
| 2023-02-06 | GSK plc | 1.01M | 4.90% |
| 2022-04-29 | 2 | 1.04M | 5.10% |
| 2022-04-29 | 2 | 1.04M | 5.10% |
| 2022-04-29 | 2 | 1.04M | 5.10% |
| 2022-04-29 | 2 | 1.04M | 5.10% |
| 2022-02-10 | Peter Justin Klein | 1.46M | 7.20% |
| 2022-02-10 | Vensana Capital I GP, LLC | 1.46M | 7.20% |
| 2022-02-10 | Vensana Capital I, L.P. | 1.46M | 7.20% |
| 2022-02-10 | Kirk Nielsen | 1.46M | 7.20% |
| 2022-02-07 | EIN: 22-2007137 | 3.5M | 17.20% |
| 2022-02-07 | EIN: 22-1024240 | 4.11M | 19.60% |
| 2021-07-15 | Scott D. Sandell | 2.2M | 11.40% |
| 2021-07-15 | NEA Partners 10, Limited Partnership | 2.2M | 11.40% |
| 2021-07-15 | New Enterprise Associates 10, Limited Partnership | 2.2M | 11.40% |
| 2021-07-15 | New Enterprise Associates 8A, Limited Partnership | 2.2M | 11.40% |
| 2021-07-12 | Martemanshurk B.V. (100% owned by Pieter van der Meer) | 1.83M | 9.00% |
| 2021-07-12 | Gilde Healthcare IV Management B.V. | 1.83M | 9.00% |
| 2021-07-12 | GlaxoSmithKline plc | 1.01M | 5.00% |
| 2021-07-12 | Gilde Healthcare Holding B.V. | 1.83M | 9.00% |
| 2021-07-12 | Marc Olivier Perret | 1.83M | 9.00% |
| 2021-07-12 | Edwin de Graaf | 1.83M | 9.00% |
| 2021-07-12 | Cooperatieve Gilde Healthcare IV U.A. | 1.83M | 9.00% |
CVRX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.10 | 26.08M | $185.2M | $75.71M | $50.79M | $160.28M |
| 2024-12-31 | $12.67 | 22.6M | $286.29M | $105.93M | $50.43M | $230.79M |
| 2023-12-31 | $31.44 | 20.7M | $650.9M | $90.57M | $30.61M | $590.95M |
| 2022-12-31 | $18.35 | 20.51M | $376.34M | $106.19M | $7.09M | $277.23M |
| 2021-12-31 | $12.23 | 20.72M | $253.41M | $142.07M | -$ | $111.33M |
| 2020-12-31 | $28.00 | 387.08K | $10.84M | $59.11M | $19.28M | -$29M |
| 2019-12-31 | $28.00 | 482.58K | $13.51M | $25.74M | $18.99M | $6.76M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9.46 | 26.36M | $249.32M | $72.3M | $59.4M | $236.42M |
| 2025-12-31 | $7.10 | 26.22M | $186.15M | $75.71M | $50.79M | $161.23M |
| 2025-09-30 | $8.07 | 26.17M | $211.18M | $85.12M | $50.52M | $176.58M |
| 2025-06-30 | $5.88 | 26.07M | $153.3M | $95.02M | $50.54M | $108.82M |
| 2025-03-31 | $12.23 | 25.88M | $316.46M | $102.67M | $50.42M | $264.22M |
| 2024-12-31 | $12.67 | 22.6M | $286.29M | $105.93M | $50.43M | $230.79M |
| 2024-09-30 | $8.81 | 22.78M | $200.72M | $100.16M | $50.44M | $151M |
| 2024-06-30 | $11.71 | 21.63M | $253.27M | $70.4M | $30.59M | $213.46M |
| 2024-03-31 | $17.97 | 21.23M | $381.54M | $80.12M | $30.6M | $332.03M |
| 2023-12-31 | $31.44 | 20.6M | $647.57M | $90.57M | $30.61M | $587.61M |
| 2023-09-30 | $15.17 | 20.8M | $315.56M | $82.99M | $15.38M | $247.94M |
| 2023-06-30 | $15.44 | 20.71M | $319.79M | $90.82M | $15.38M | $244.36M |